ESCRS 2023: Integrated workflow solutions in cataract procedures

News
Video

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Euan Thomson: So I'm Euan Thompson, I'm President of Ophthalmology at Carl Zeiss, and Head of Digital Business. You know, we're working very hard on creating integrated workflow solutions. This is a big theme for us. And I think that, as people go around our booth, there's actually going to be a high level of integration that we've already been able to achieve.

Some of our workflows are complete; cataract workflow, for example, is there. And we've actually been able to demonstrate the value of this to customers. So we're really targeting new value propositions beyond the technology itself. We're really looking at efficiency gains in the operating room efficiency gains in the run up to a treatment. We're looking at quality improvement, standardization, and we're actually already gathering data on these. So we're really excited about that and really looking forward to showcasing it today.

So what I'm looking forward to in 2024, is really, really demonstrating the power of the level of integration that we've achieved, you know, our digitally connected workflows are really quite evolved now. The true value of those in terms of, you know, the efficiency gains and standardization and so on these new value propositions, being able to test those and getting the data back is really exciting, you know. A cataract workflow, we've actually now got demonstrable data that shows that there is a true efficiency gain, not just in the run up to a treatment but in the operating room itself. And it can be as high as 30% timesaving in the operating room for some procedures. So this is meaningful improvements in the standard of care.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.